Natural Antisense Inhibition Results in Transcriptional De-Repression and Gene Upregulation

By F. Modarresi, M. Faghihi, Miguel A Lopez-Toledano, Roya Pedram Fatemi, Marco Magistri, S. Brothers, M. P. van der Brug, Claes Wahlestedt. Nature Biotechnology, 2012

626 citations recorded by the source corpus.

The ability to specifically upregulate genes in vivo holds great therapeutic promise. Here we show that inhibition or degradation of natural antisense transcripts (NATs) by single-stranded oligonucleotides or siRNAs can transiently and reversibly upregulate locus-specific gene expression. Brain-derived neurotrophic factor (BDNF) is normally repressed by a conserved noncoding antisense RNA transcript, BDNF-AS. Inhibition of this transcript upregulates BDNF mRNA by two- to sevenfold, alters chromatin marks at the BDNF locus, leads to increased protein levels and induces neuronal outgrowth and differentiation both in vitro and in vivo. We also show that inhibition of NATs leads to increases in glial-derived neurotrophic factor (GDNF) and ephrin receptor B2 (EPHB2) mRNA. Our data suggest that pharmacological approaches targeting NATs can confer locus-specific gene upregulation effects.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/da52c8fee95e1e85e0980090ed05a9f690acdc56

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

  1. Pedro J. Batista
  2. Melissa Jane Fullwood
  3. Yiwen Fang
  4. Howard Y. Chang
  5. Ling-Ling Chen
  6. Jeannie T. Lee
  7. M. Bartolomei

In Molecular Biology

  1. Pedro J. Batista
  2. Melissa Jane Fullwood
  3. Yiwen Fang
  4. Howard Y. Chang
  5. Caterina Catalanotto
  6. G. Zardo
  7. C. Cogoni
  8. Ling-Ling Chen

Citations in the corpus